Aveanna Healthcare Holdings (AVAH) has received a new Buy rating, initiated by BMO Capital analyst, .
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BMO Capital has given its Buy rating due to a combination of factors including Aveanna Healthcare Holdings’ recent financial performance and strategic initiatives. The company has seen a significant increase in its stock value, driven by successful state reimbursement rate increases and effective cost management, which have collectively reduced its leverage ratio.
Furthermore, Aveanna’s strategy to negotiate higher reimbursement rates with payers allows it to offer competitive wages to caregivers, addressing the supply-demand imbalance in the home-care sector. This approach not only attracts more caregivers but also increases patient volumes, contributing to a positive long-term EBITDA growth outlook. The company’s efforts to expand its preferred payer arrangements and its focus on value-based care arrangements further support BMO Capital’s optimistic view on its future performance.
In another report released on November 7, Barclays also maintained a Buy rating on the stock with a $9.00 price target.